乌鸦传媒

Advisory committee members put their foot down on shaky science

Clinicians should perform liver blood tests before and during Veozah treatment

Agency advisory panel to examine complicated efficacy data and liver safety concerns

This difference is mostly explained by their smaller stature, researchers say

Patients who lacked a follow-up visit may be at particularly high risk for death

Also in TTHealthWatch: suicidality among spouses of people with cancer

No difference from placebo in transfusion rate, blood loss, with higher complication rate

Seladelpar improved biochemical response, ALP normalization versus placebo in phase III trial

And liver injuries tied to herbal and dietary supplements are on the rise, data show

National cohort study finds up to 47% fewer serious hemorrhagic events with one agent

Also in TTHealthWatch: medications and the liver, and managing gestational diabetes

Results as quick as 1 hour, enabling a test-and-treat approach

Case reports may not be as reliable, researchers say

Phase II data support testing pemvidutide for comorbid obesity and liver conditions